Company
Insys Therapeutics, Inc. (0001516479)
Standardized SEC financial data for Insys Therapeutics, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001516479 · Pharmaceutical Preparations.
Gross margin
85.3%
Operating margin
-90.8%
Net margin
-88.5%
Revenue growth (YoY)
-41.9%
Return on equity
288.9%
Free cash flow
-$62.1M
Current ratio
1.18×
EPS (diluted)
$-1.68
Ratios for fiscal year 2017, standardized from SEC filings.
Income statement
| USD | FY2016 | FY2017 | FY2018 |
|---|---|---|---|
| Revenue | $242.3M | $140.7M | — |
| Cost of revenue | $25.4M | $20.6M | $10.8M |
| Gross profit | $216.9M | $120.0M |
Balance sheet
| USD | FY2016 | FY2017 | FY2018 |
|---|---|---|---|
| Cash & equivalents | $104.6M | $32.0M | $104.1M |
| Inventory | $20.4M | $17.4M | $8.6M |
| Total current assets | $229.6M | $175.9M |
Cash flow
| USD | FY2016 | FY2017 | FY2018 |
|---|---|---|---|
| Operating cash flow | $58.9M | -$60.7M | -$56.0M |
| Capital expenditures | $10.6M | $16.7M | $6.1M |
| Free cash flow | $48.3M | -$77.3M |
Get 0001516479 data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001516479/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001516479/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"